Grain supplier Seednet has agreed to pay $1 million to settle an enforcement action by the consumer watchdog alleging it misled farmers about the performance of its latest barley variety.
A court has told the Australian Securities and Investments Commission to produce more detailed allegations against former Tennis Australia directors Harold Mitchell and Stephen Healy over Seven Network’s five-year deal for the broadcast rights to the Australian Open after the regulator was slammed for a vague filing.
Embattled wealth manager AMP has revealed its fees for no service scandal could cost the firm more than $1 billion in customer remediation, and that it might be facing another fees scandal.
A unit of Nestle unit has defeated an opposition to a patent for an internet-connected coffee machine that would allow users to read news and weather while making their morning coffee.
GlaxoSmithKline has won approval for a patent for a vaccine to prevent a common respiratory virus affecting infants, beating out a challenge from a rival that has developed a competing vaccine.
Liberal Democrat senator David Leyonhjelm has made good on his threat to challenge a ruling that kept alive a defamation lawsuit brought by Greens senator Sarah Hanson-Young after he accused her of labelling all men rapists on the sidelines of a Senate debate.
Squire Patton Boggs has refused a request by rival Phi Finney McDonald for the details of group members it signed up to its now stayed shareholder class action against GetSwift, a court has learned, in the latest show of resistance by the losing law firm.
An expert witness in an investor class action against Fitch Ratings over toxic financial products is no expert at all, the lead applicant told the court in contesting the admissibility of the expert’s evidence.
Vocational education provider Captain Cook College has panned the ACCC for delaying its recently filed case against the college by failing to prepare a statement of claim, despite already publicising the proceedings.
Consumer goods giant Reckitt Benckiser is seeking more information after advertisements for rival AFT Pharmaceuticals’ Maxigesic painkiller were found in-store and online despite the court ordering the removal of the misleading displays earlier this month.